ALYSSA ORR: Open Payments
NPI 1770324964 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 35 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $139 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| Astellas Pharma US Inc | 5 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 1 | $31 |
Products named: AIRSUPRA, Veozah, CAPLYTA, UBRELVY, QULIPTA, MOUNJARO, VRAYLAR, Wegovy.
Industry payments across AZ — which companies pay providers there.
